ICOS and cancer: Besides, patients with higher levels of Faecalibacterium demonstrated an increase in the expression of inducible T cell co-stimulator (ICOS) on T cells, which has been reported as a potential biomarker for the effectiveness of ipilimumab treatment in cancer patients.50